Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking

The novel coronavirus disease (COVID-19) caused by SARS-CoV-2 virus spreads rapidly to become a global pandemic. Researchers have been working to develop specific drugs to treat COVID-19. The main protease (M(pro)) of SARS-CoV-2 virus plays a pivotal role in mediating viral replication and transcrip...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xinbo, Xing, Xianrong, Liu, Yirui, Zheng, Yuanjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579442/
https://www.ncbi.nlm.nih.gov/pubmed/36278156
http://dx.doi.org/10.3389/fphar.2022.962863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579442/
https://www.ncbi.nlm.nih.gov/pubmed/36278156
http://dx.doi.org/10.3389/fphar.2022.962863

Ejemplares similares